Viatris, Inc.

( )
VTRS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.47%168.090.7%$1318.62m
PFEPfizer Inc. 0.76%39.650.9%$1302.97m
MRKMerck & Co., Inc. 0.63%77.950.7%$905.40m
BMYBristol-Myers Squibb Co. 0.39%64.511.0%$717.86m
ABBVAbbVie, Inc. -0.04%114.851.9%$713.53m
LLYEli Lilly & Co. -0.85%193.091.1%$576.25m
AZNAstraZeneca Plc 0.74%54.501.2%$541.26m
BTXBrooklyn ImmunoTherapeutics, Inc. -9.87%27.5812.8%$315.56m
GSKGlaxoSmithKline Plc 0.37%38.330.2%$193.08m
NVSNovartis AG 0.17%87.560.2%$168.03m
VTRSViatris, Inc. 3.83%15.720.0%$157.17m
CVACCureVac NV -4.09%93.960.0%$138.75m
SNYSanofi -0.35%51.770.2%$69.73m
NVONovo Nordisk A/S 1.95%78.110.1%$65.90m
MNMDMind Medicine (MindMed), Inc. -5.20%2.920.0%$60.53m

Company Profile

Viatris, Inc. is a healthcare company, which engages in the provision of access to medicines, sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.